Ultraviolet light phototherapy for allergic rhinitis

Journal of Photochemistry and Photobiology B: Biology

Volumn 87, Issue 1, 2007, Pages 58-65

  Kemény, Lajos ^a   Koreck, Andrea ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Allergic rhinitis; Immunosuppression; Phototherapy

Indexed keywords

CORTICOSTEROID; METHOXSALEN;

ALLERGIC RHINITIS; APOPTOSIS; BIOLOGY; CLINICAL PROTOCOL; CLINICAL TRIAL; DENDRITIC CELL; DNA DAMAGE; EXCIMER LASER; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LIGHT; MUCOSAL DRYNESS; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; RADIATION DOSE; RANDOMIZATION; REVIEW; RHINORRHEA; SCORING SYSTEM; SKIN CANCER; SNEEZING; SYMPTOM; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; XEROSIS;

DERMATITIS, CONTACT; DNA DAMAGE; HUMANS; PHOTOTHERAPY; RHINITIS, ALLERGIC, SEASONAL; ULTRAVIOLET RAYS;

AMBROSIA;

EID: 33847341201     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2007.01.001     Document Type: Review

References (50)

1. Hamzavi I., and Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatol. Clin. 23 (2005) 199-207
2. Weichenthal M., and Schwarz T. Phototherapy: how does UV work?. Photodermatol. Photoimmunol. Photomed. 21 (2005) 260-266
3. Ozawa M., Ferenczi K., Kikuchi T., Cardinale I., Austin L.M., Coven T.R., Burack L.H., and Krueger J.G. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J. Exp. Med. 189 (1999) 711-718
4. Novak Z., Berces A., Ronto G., Pallinger E., Dobozy A., and Kemeny L. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem. Photobiol. 79 (2004) 434-439
5. Morita A., Werfel T., Stege H., Ahrens C., Karmann K., Grewe M., Grether-Beck S., Ruzicka T., Kapp A., Klotz L.O., Sies H., and Krutmann J. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J. Exp. Med. 186 (1997) 1763-1768
6. Matsunaga T., Hieda K., and Nikaido O. Wavelength dependent formation of thymine dimers and (6-4) photoproducts in DNA by monochromatic ultraviolet light ranging from 150 to 365 nm. Photochem. Photobiol. 54 (1991) 403-410
7. Aragane Y., Kulms D., Metze D., Wilkes G., Poppelmann B., Luger T.A., and Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140 (1998) 171-182
8. Kulms D., Zeise E., Poppelmann B., and Schwarz T. DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 21 (2002) 5844-5851
9. Kalimo K., Koulu L., and Jansen C.T. Effect of a single UVB or PUVA exposure on immediate and delayed skin hypersensitivity reactions in humans. Correlation to erythemal response and Langerhans cell depletion. Arch. Dermatol. Res. 275 (1983) 374-378
10. Furio L., Berthier-Vergnes O., Ducarre B., Schmitt D., and Peguet-Navarro J. UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells. J. Invest. Dermatol. 125 (2005) 1032-1038
11. Hurks H.M., Out-Luiting C., Vermeer B.J., Claas F.H., and Mommaas A.M. The action spectra for UV-induced suppression of MLR and MECLR show that immunosuppression is mediated by DNA damage. Photochem. Photobiol. 62 (1995) 449-453
12. Luger T.A., and Schwarz T. Effects of UV-light on cytokines and neuroendocrine hormones. In: Elmets C., and Krutman J. (Eds). Photoimmunology (1995), Blackwell, London 55-76
13. Monfrecola G., de Paulis A., Prizio E., Russo I., Carfora M., Santoianni P., and Marone G. In vitro effects of ultraviolet A on histamine release from human basophils. J. Eur. Acad. Dermatol. Venereol. 17 (2003) 646-651
14. Guhl S., Stefaniak R., Strathmann M., Babina M., Piazena H., Henz B.M., and Zuberbier T. Bivalent effect of UV light on human skin mast cells-low-level mediator release at baseline but potent suppression upon mast cell triggering. J. Invest. Dermatol. 124 (2005) 453-456
15. Walters I.B., Ozawa M., Cardinale I., Gilleaudeau P., Trepicchio W.L., Bliss J., and Krueger J.G. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch. Dermatol. 139 (2003) 155-161
16. Schwarz A., Beissert S., Grosse-Heitmeyer K., Gunzer M., Bluestone J.A., Grabbe S., and Schwarz T. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol. 165 (2000) 1824-1831
17. Schwarz A., Maeda A., Wild M.K., Kernebeck K., Gross N., Aragane Y., Beissert S., Vestweber D., and Schwarz T. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172 (2004) 1036-1043
18. Niederberger V., Stubner P., Spitzauer S., Kraft D., Valenta R., Ehrenberger K., and Horak F. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J. Invest. Dermatol. 117 (2001) 848-851
19. Vocks E., Stander K., Rakoski J., and Ring J. Suppression of immediate-type hypersensitivity elicitation in the skin prick test by ultraviolet B irradiation. Photodermatol. Photoimmunol. Photomed. 15 (1999) 236-240
20. Csoma Z., Ignacz F., Bor Z., Szabo G., Bodai L., Dobozy A., and Kemeny L. Intranasal irradiation with the xenon chloride ultraviolet B laser improves allergic rhinitis. J. Photochem. Photobiol. B: Biol. 75 (2004) 137-144
21. Csoma Z., Koreck A., Ignacz F., Bor Z., Szabo G., Bodai L., Dobozy A., and Kemeny L. PUVA treatment of the nasal cavity improves the clinical symptoms of allergic rhinitis and inhibits the immediate-type hypersensitivity reaction in the skin. J. Photochem. Photobiol. B: Biol. 83 (2006) 21-26
22. Koreck A., Csoma Z., Boros-Gyevi M., Ignacz F., Bodai L., Dobozy A., and Kemeny L. Inhibition of immediate type hypersensitivity reaction by combined irradiation with ultraviolet and visible light. J. Photochem. Photobiol. B: Biol. 77 (2004) 93-96
23. Kronauer C., Eberlein-Konig B., Ring J., and Behrendt H. Influence of UVB, UVA and UVA1 irradiation on histamine release from human basophils and mast cells in vitro in the presence and absence of antioxidants. Photochem. Photobiol. 77 (2003) 531-534
24. Lundquist G., Forsgren H., Gajecki M., and Emtestam L. Photochemotherapy of oral lichen planus. A controlled study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 79 (1995) 554-558
25. Redding S.W., Callander N.S., Haveman C.W., and Leonard D.L. Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 86 (1998) 183-187
26. Trehan M., and Taylor C.R. Low-dose excimer 308-nm laser for the treatment of oral lichen planus. Arch. Dermatol. 140 (2004) 415-420
27. Kay A.B. Allergy and allergic diseases. First of two parts. New Engl. J. Med. 344 (2001) 30-37
28. Berneburg M., Rocken M., and Benedix F. Phototherapy with narrowband vs broadband UVB. Acta Derm. Venereol 85 (2005) 98-108
29. Bonis B., Kemeny L., Dobozy A., Bor Z., Szabo G., and Ignacz F. 308 nm UVB excimer laser for psoriasis. Lancet 350 (1997) 1522
30. Asawanonda P., Anderson R.R., Chang Y., and Taylor C.R. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch. Dermatol. 136 (2000) 619-624
31. Trehan M., and Taylor C.R. High-dose 308-nm excimer laser for the treatment of psoriasis. J. Am. Acad Dermatol. 46 (2002) 732-737
32. Baltas E., Csoma Z., Ignacz F., Dobozy A., and Kemeny L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch. Dermatol. 138 (2002) 1619-1620
33. Baltas E., Csoma Z., Bodai L., Ignacz F., Dobozy A., and Kemeny L. Treatment of atopic dermatitis with the xenon chloride excimer laser. J. Eur. Acad. Dermatol. Venereol. 20 (2006) 657-660
34. Koreck A.I., Csoma Z., Bodai L., Ignacz F., Kenderessy A.S., Kadocsa E., Szabo G., Bor Z., Erdei A., Szony B., Homey B., Dobozy A., and Kemeny L. Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J. Allergy Clin. Immunol. 115 (2005) 541-547
35. Koreck A., Csoma Z., Boros-Gyevi M., and Kemeny L. Comparison of the efficacy of intranasal phototherapy and fexofenadine hydrochloride for the treatment of seasonal allergic rhinitis. Clin. Immunol. Suppl. 1 (2005) S50
36. Raiss M., Templier I., and Beani J.C. Skin cancer and psoralen plus UVA: a retrospective study of 106 patients exposed to a great number of PUVA treatments. Ann. Dermatol. Venereol. 131 (2004) 437-443
37. Stern R.S., and Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J. Invest. Dermatol. 91 (1988) 120-124
38. Abeck D., Schmidt T., Fesq H., Strom K., Mempel M., Brockow K., and Ring J. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J. Am. Acad. Dermatol 42 (2000) 254-257
39. Lee E., Koo J., and Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int. J. Dermatol. 44 (2005) 355-360
40. Kita H., Jorgensen R.K., Reed C.E., Dunnette S.L., Swanson M.C., Bartemes K.R., Squillace D., Blomgren J., Bachman K., and Gleich G.J. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. J. Allergy Clin. Immunol. 106 (2000) 521-529
41. Berthon B., Taudou G., Combettes L., Czarlewski W., Carmi-Leroy A., Marchand F., and Weyer A. In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3). Biochem. Pharmacol. 47 (1994) 789-794
42. Howarth P.H., Bradding P., Feather I., Wilson S., Church M.K., and Holgate S.T. Mucosal cytokine expression in allergic rhinitis. Int. Arch. Allergy Immunol. 107 (1995) 390-391
43. Bradding P., Feather I.H., Wilson S., Holgate S.T., and Howarth P.H. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am. J Respir. Crit. Care Med. 151 (1995) 1900-1906
44. Hoffmann A., Jamin A., Foetisch K., May S., Aulepp H., Haustein D., and Vieths S. Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of beta-hexosaminidase release from RBL-2H3 cells. Comparison with classical methods in allergen standardization. Allergy 54 (1999) 446-454
45. Ying S., Durham S.R., Barkans J., Masuyama K., Jacobson M., Rak S., Lowhagen O., Moqbel R., Kay A.B., and Hamid Q.A. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am. J Respir. Cell Mol. Biol. 9 (1993) 356-360
46. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien F., Noble W., Till S.J., Hamid Q.A., and Nouri-Aria K.T. Long-term clinical efficacy of grass-pollen immunotherapy. New Engl. J Med. 341 (1999) 468-475
47. Wilson D.R., Nouri-Aria K.T., Walker S.M., Pajno G.B., O'Brien F., Jacobson M.R., Mackay I.S., and Durham S.R. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J. Allergy Clin. Immunol. 107 (2001) 971-976
48. Benson M., Strannegard I.L., Strannegard O., and Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J. Allergy Clin. Immunol. 106 (2000) 307-312
49. Holgate S.T. The role of mast cells and basophils in inflammation. Clin. Exp. Allergy 30 Suppl. 1 (2000) 28-32
50. Simons F.E. H1-Antihistamines: more relevant than ever in the treatment of allergic disorders. J. Allergy Clin. Immunol. 112 4. Suppl. (2003) S42-S52